PRA’s Vaccine Solutions group understands the unique challenges and characteristics of vaccine development. Right from the start, our experts will evaluate your clinical program needs and develop the most efficient study strategy.
Meeting Enrollment Goals Breast Cancer
An open-label, randomized, multi-center study to evaluate the use of Study Drug in the prevention of cancer treatment-related bone loss in…
Wearables and Virtual Trials
At PRA, we’re elevating clinical trial design to work for patients in today’s modern world. By leveraging our data, expertise, and technologies, we…
Early Engagement Crucial to Develop Trial Design for Accelerated Schedule Vaccine Study
A case study describing PRA's involvement in an accelerated schedule vaccine study for poliomyelitis.